Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.69 +1.48 (+3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Return on Assets [ROA] (2021 - 2026)

Updated

Bright Minds Biosciences' Return on Assets [ROA] was 1.83% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 8.81 percentage points from 10.64% a year earlier and down 4.76 percentage points from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Return on Assets [ROA] at Bright Minds Biosciences came in at -26.97%, up 15.99 percentage points from FY2024.

  • Return on Assets [ROA] has now increased for three consecutive fiscal years, with a five-year change of +72.72 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, Return on Assets [ROA] was -42.96% in FY2024 (+32.10 pp), -75.06% in FY2023 (+92576702.23 pp), -92576777.28% in FY2022 (-9667453.88 pp) and -82909323.41% in FY2021 (-82909223.71 pp).
  • Quarterly Return on Assets [ROA] has moved between -167681982.23% (fiscal Q3 2023) and 10.64% (fiscal Q3 2025) over five years.
  • Compared with a year earlier, Return on Assets [ROA] was higher in five of the last eight quarters, with an average year-over-year change of +56.36 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q3 2024 (a gain of 167681852.06 percentage points); the worst was fiscal Q3 2026 (a drop of 8.81 percentage points).
  • Per Business Quant data, DRUG's Return on Assets [ROA] in the three fiscal quarters before Q3 2026 was 6.59% (Q2 2026), -13.86% (Q1 2026) and -5.49% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Bright Minds Biosciences 387.06 Mn 387.06 Mn - 1.83%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.83%
Mar 31, 2026 6.59%
Dec 31, 2025 -13.86%
Sep 30, 2025 -5.49%
Jun 30, 2025 10.64%
Mar 31, 2025 1.22%
Dec 31, 2024 -6.17%
Sep 30, 2024 -59.50%
Jun 30, 2024 -130.17%
Mar 31, 2024 -149.33%
Dec 31, 2023 -123.75%
Sep 30, 2023 -58.58%
Jun 30, 2023 -167,681,982.23%
Mar 31, 2023 -144,367,013.54%
Dec 31, 2022 -129,096,541.18%
Sep 30, 2021 -13.10%
API Access

Bright Minds Biosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DRUG&period=max&api_key=YOUR_API_KEY